### ðŸ«€ Cardiology: Papillary Fibroelastoma Management

#### âœ… True Statements
1. **Papillary fibroelastoma** is the **third most common benign cardiac tumor**, following **cardiac myxoma** and **cardiac lipoma**.  
2. **Papillary fibroelastomas** arise **predominantly from cardiac valves**, most frequently the **aortic** and **mitral valves**.  
3. The **papillary frondâ€‘like architecture** of a **fibroelastoma** predisposes to **embolization** of tumor fragments or attached thrombus into the **coronary, systemic, or cerebral arterial circulation**.  
4. **Transesophageal echocardiography (TEE)** typically shows a **heterogeneous globular mass** or a **mobile frondâ€‘like lesion** attached to the **valvular surface** in papillary fibroelastoma.  
5. **Surgical resection** is the **recommended treatment** for patients with **papillary fibroelastoma** who have experienced **embolic symptoms** such as **transient ischemic attack (TIA) or stroke**.  
6. Asymptomatic **papillary fibroelastomas â‰¥1â€¯cm** in size are generally **treated surgically** because of their high embolic potential.  
7. For **asymptomatic papillary fibroelastomas <1â€¯cm** arising from **rightâ€‘sided heart valves**, **clinical and imaging surveillance** may be considered instead of immediate surgery.  
8. There are **no randomized trials** comparing **surgery** versus **antithrombotic or antiplatelet therapy** for the prevention of embolic events in **incidentally discovered papillary fibroelastoma**.  
9. **Antibiotic therapy** is **not indicated** for a **papillary fibroelastoma** in the **absence of infective endocarditis**.  
10. **Longâ€‘term anticoagulation with warfarin** is **not an accepted substitute** for **surgical excision** of an **embolizing papillary fibroelastoma**.

#### ðŸ’¬ Extra
1. Cardiac tumors are rare overall, and **fibroelastomas** account for approximately **8%â€“10%** of benign primary cardiac tumors.  
2. Leftâ€‘sided valve location and a highly mobile morphology increase the likelihood of **neurologic** or **coronary embolization**.  
3. Highâ€‘resolution **TEE** is more sensitive than **transthoracic echocardiography (TTE)** for detecting small valvular masses.  
4. **Surgical excision** of a solitary fibroelastoma is usually curative and carries a **low operative risk**.  
5. Smaller, rightâ€‘sided fibroelastomas pose **minimal systemic embolic risk** because any emboli enter the **pulmonary circulation**.

#### ðŸ”· Tags
#Cardiology #UrgentCare #HospitalCare #PatientOver65 #CardiacTumor #PapillaryFibroelastoma #EmbolicStroke

#### ðŸ“™ Reference
Tyebally S, Chen D, Bhattacharyya S, etâ€¯al. **Cardiac tumors: JACC CardioOncology stateâ€‘ofâ€‘theâ€‘art review**. *JACC CardioOncol*. 2020;2:293â€‘311. PMID:â€¯34396236. doi:10.1016/j.jaccao.2020.05.009

#### ðŸ†” Question ID
CVMCQ24075

#### ðŸ•’ Last Updated
Februaryâ€¯2025

---
#### ðŸ“– Related Text
MKSAP 19: Cardiovascular Medicine â€” Myocardial Disease, Cardiac Tumors

---

### ðŸ“˜ Related Text Derivations

#### âœ… True Statements
1. **Most cardiac tumors** are **metastatic** rather than primary.  
2. **Melanoma**, **malignant thymoma**, and **germ cell tumors** have the **highest propensity** to **metastasize to the heart**.  
3. **Carcinomas of the lung, stomach, and colon** carry an **intermediate risk** for **cardiac metastasis**.  
4. Management of **metastatic cardiac tumors** focuses on **systemic therapy** of the **primary malignancy**, with **cardiac surgery** reserved for **obstructive cardiac symptoms**.  
5. **Twoâ€‘thirds of primary cardiac tumors are benign**, and **approximately 50%** of these are **atrial myxomas**.  
6. **Atrial myxomas** most often attach to the **fossa ovalis** of the **left atrial septum**.  
7. **Atrial myxomas** are usually **solitary** and are typically identified at a **mean age of about 50 years**, frequently **after a systemic embolic event**.  
8. Clinical manifestations of **atrial myxoma** include **constitutional symptoms** driven by **interleukin secretion**, **embolization of tumor fragments**, and **intracardiac obstructionâ€“related symptoms** such as **dyspnea** or **syncope**.  
9. When **mitral valve obstruction** by an **atrial myxoma** is present, auscultation may reveal an **early diastolic â€œtumor plopâ€** and findings that **mimic mitral stenosis** but **vary with body position**.  
10. **Surgical excision** of an **atrial myxoma** is indicated to **prevent embolic events**, and **surveillance echocardiography** is recommended to detect **tumor recurrence**.  
11. **Papillary fibroelastomas** are usually **asymptomatic**, but they can lead to **stroke**, **transient ischemic attack**, or **coronary embolization**.  
12. **Angiosarcoma** is the **most common primary malignant cardiac tumor**, typically arising in the **right atrium** and often associated with a **pericardial effusion**.  
13. **Dyspnea** and **chest pain** are common presenting symptoms of **cardiac angiosarcoma**.  
14. **Contrastâ€‘enhanced computed tomography (CT) or cardiac magnetic resonance (CMR)** helps **distinguish a right atrial angiosarcoma** from a **right atrial myxoma** because **angiosarcomas are highly vascular**.  
15. Prognosis of **cardiac angiosarcoma** is **poor**, with **median survival of 6â€“12 months** and **survival <2 years** even after **complete surgical resection**.

#### ðŸ’¬ Extra
2. High melanin content and aggressive hematogenous spread explain melanomaâ€™s predilection for cardiac metastasis.  
4. Obstructive symptoms include superior vena cava syndrome, heart failure, or arrhythmias due to intracardiac mass effect.  
7. Systemic emboli from myxoma commonly affect the brain, kidneys, or extremities.  
11. The majority of fibroelastomas are discovered incidentally on echocardiography performed for other reasons.  
14. On CMR, angiosarcomas show heterogeneous signal intensity and avid contrast enhancement reflective of tumor vascularity.

#### ðŸ·ï¸ Tags
#Cardiology #CardiacTumors #MetastaticCancer #AtrialMyxoma #Fibroelastoma #Angiosarcoma #CardiacImaging #PericardialEffusion #IntracardiacObstruction #EmbolicStroke

#### ðŸ–¼ï¸ Supplemental Figures and Media

<figure>
  <img src="TTE of Left Atrial Myxoma and Image of Excised Tumor.jpg" alt="Transthoracic Echocardiogram of Left Atrial Myxoma and Image of Excised Tumor">
  <figcaption>
    <strong>Transthoracic Echocardiogram of Left Atrial Myxoma and Image of Excised Tumor.</strong><br>
    A, Transthoracic echocardiogram during diastole demonstrating a left atrial myxoma originating from the interatrial septum and prolapsing across the mitral valve (MV) into the left ventricle (LV).<br>
    B, Parasternal longâ€‘axis view.<br>
    C, Gross photograph of the excised myxoma with a portion of the fossa ovalis (arrow) attached.<br>
    LA = left atrium; RA = right atrium; RV = right ventricle.
  </figcaption>
</figure>

<figure>
  <video controls width="600">
    <source src="Echocardiogram Showing Left Atrial Myxoma.mp4" type="video/mp4">
    Your browser does not support the video tag.
  </video>
  <figcaption>
    <strong>Echocardiogram Showing Left Atrial Myxoma.</strong><br>
    The transthoracic fourâ€‘chamber view echocardiogram shows a solid, nearly uniformâ€‘appearing mobile mass in the left atrium passing into the mitral valve orifice.<br>
    The transesophageal echocardiogram shows a mobile, highly cystic mass in the left atrium consistent with an atrial myxoma.<br>
    Video courtesy of Kevin Curl, MD, FACP, FACC, Virtua Cardiology Group, Voorhees, New Jersey.
  </figcaption>
</figure>

<figure>
  <img src="CMRI of an Angiosarcoma.jpg" alt="Cardiac Magnetic Resonance Image in a Patient With an Angiosarcoma">
  <figcaption>
    <strong>Cardiac Magnetic Resonance Image in a Patient With an Angiosarcoma.</strong><br>
    A heterogeneous mass (white arrow) is infiltrating the right atrial wall. A pericardial effusion (yellow arrow) is also present.
  </figcaption>
</figure>
